The Mechanism and Management of Adverse Cardiac Reactions Induced by Immune Checkpoint Inhibitors Therapy

Joint Authors

Rong, Fangning
Ji, Kangting
Weng, Yingpei
Peng, Yangpei

Source

Cardiology Research and Practice

Issue

Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-5, 5 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2020-12-16

Country of Publication

Egypt

No. of Pages

5

Main Subjects

Diseases

Abstract EN

Immune checkpoint inhibitors (ICIs) therapy has recently been introduced to all kinds of cancers.

The adverse reactions associated with this therapy have attracted much attention.

The heart-related adverse reactions are mainly the immune-related myocarditis and heart failure.

Cases of adverse cardiac reactions caused by ICIs therapy have been clearly reported.

However, the pathogenesis of the adverse cardiac reactions remains unclear.

Therefore, this article briefly reviews the mechanism and management of adverse cardiac reactions caused by ICIs therapy.

American Psychological Association (APA)

Rong, Fangning& Ji, Kangting& Weng, Yingpei& Peng, Yangpei. 2020. The Mechanism and Management of Adverse Cardiac Reactions Induced by Immune Checkpoint Inhibitors Therapy. Cardiology Research and Practice،Vol. 2020, no. 2020, pp.1-5.
https://search.emarefa.net/detail/BIM-1152614

Modern Language Association (MLA)

Rong, Fangning…[et al.]. The Mechanism and Management of Adverse Cardiac Reactions Induced by Immune Checkpoint Inhibitors Therapy. Cardiology Research and Practice No. 2020 (2020), pp.1-5.
https://search.emarefa.net/detail/BIM-1152614

American Medical Association (AMA)

Rong, Fangning& Ji, Kangting& Weng, Yingpei& Peng, Yangpei. The Mechanism and Management of Adverse Cardiac Reactions Induced by Immune Checkpoint Inhibitors Therapy. Cardiology Research and Practice. 2020. Vol. 2020, no. 2020, pp.1-5.
https://search.emarefa.net/detail/BIM-1152614

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1152614